Artificial liver to replace animal testing, potential to accelerate development of new drugs

Credit: Colin Hattersley

Scientists at Heriot-Watt University are working towards creating the world's first artificial human livers for drug testing to drastically cut the number of live animals used and get life-saving medicines into the clinic faster.

Dr Will Shu is leading the Heriot-Watt University team in the £100,000 project. Working closely with Roslin Cellab, the team aims to demonstrate how an artificial liver, created using , could become a new testing platform for discovery and development.

The team is working towards creating miniature human liver tissues and, eventually, 'livers-on-a-chip', using that will 'print' the cells in 3D onto testing surfaces.

Dr Will Shu said, "If we are able to advance this technique, the medical benefits could be enormous."

Testing new drugs currently requires large numbers of experimental animals. This work is expensive, time-consuming and is often inconclusive since drugs that pass animal testing usually fail during the even more expensive clinical stages of development, when the first human subjects are used.

Dr Jason King of Roslin Cellab said, "If successful, this technology will enable drug developers to test using models at a much earlier stage. It should highlight drug failures well before they reach the clinic and help target resources towards the most promising new ."

There is growing interest in the cell-printing technique from scientists internationally because 3D cells, such as those being developed by Dr Shu's team, outperform cells grown in 2D cultures, which until now have been the standard in the drug development sector.

The research is currently funded by the Scottish Universities Physics Alliance (SUPA) INSPIRE programme.

Roslin Cellab is a Roslin Foundation company that offers contract research and is now using human cells to develop liver models for pre-clinical testing.

add to favorites email to friend print save as pdf

Related Stories

Breakthrough could speed drug discovery

Nov 25, 2011

(Medical Xpress) -- Innovative technology being pioneered at Cardiff to speed up the discovery of new drugs to tackle lung diseases could also dramatically reduce testing on animals.

Engineer builds tissue models to study diseases

May 12, 2011

Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a ...

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

16 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

Here's how the prion protein protects us

21 hours ago

The cellular prion protein (PrPC) has the ability to protect the brain's neurons. Although scientists have known about this protective physiological function for some time, they were lacking detailed knowledge ...

Regulation of maternal miRNAs in early embryos revealed

22 hours ago

The Center for RNA Research at the Institute for Basic Science (IBS) has succeeded in revealing, for the first time, the mechanism of how miRNAs, which control gene expression, are regulated in the early embryonic stage.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.